SciScore for 10.1101/2021.10.21.465252: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
<table><tr><td style="min-width:100px;margin-right:1em; border-right:1px solid lightgray; border-bottom:1px solid lightgray">Ethics</td><td style="min-width:100px;border-bottom:1px solid lightgray">not detected.</td></tr><tr><td style="min-width:100px;margin-right:1em; border-right:1px solid lightgray; border-bottom:1px solid lightgray">Sex as a biological variable</td><td style="min-width:100px;border-bottom:1px solid lightgray">2.1 Mice: Male and female BALB/c and K18-hACE2 mice (aged 6–10 weeks) were obtained from the HKU Laboratory Animal Unit</td></tr><tr><td style="min-width:100px;margin-right:1em; border-right:1px solid lightgray; border-bottom:1px solid lightgray">Randomization</td><td style="min-width:100px;border-bottom:1px solid lightgray">not detected.</td></tr><tr><td style="min-width:100px;margin-right:1em; border-right:1px solid lightgray; border-bottom:1px solid lightgray">Blinding</td><td style="min-width:100px;border-bottom:1px solid lightgray">not detected.</td></tr><tr><td style="min-width:100px;margin-right:1em; border-right:1px solid lightgray; border-bottom:1px solid lightgray">Power Analysis</td><td style="min-width:100px;border-bottom:1px solid lightgray">not detected.</td></tr><tr><td style="min-width:100px;margin-right:1em; border-right:1px solid lightgray; border-bottom:1px solid lightgray">Cell Line Authentication</td><td style="min-width:100px;border-bottom:1px solid lightgray">not detected.</td></tr></table>Table 2: Resources
<table><tr><th style="min-width:100px;text-align:center; padding-top:4px;" colspan="2">Antibodies</th></tr><tr><td style="min-width:100px;text=align:center">Sentences</td><td style="min-width:100px;text-align:center">Resources</td></tr><tr><td style="min-width:100px;vertical-align:top;border-bottom:1px solid lightgray">2.8 Surface and intracellular cytokine staining (ICS): The lung cells of mice were washed one time with staining buffer (PBS contained 2% FBS) followed by staining with anti-mouse antibodies for 30 min at 4 □, including dead cell dye (Zombie Aqua, Biolegend Cat# 423102), CD19-FITC (Biolegend Cat# 152404, RRID: AB_2629813), CD11b-PerCP/Cy5.5 (Biolegend Cat# 101228, RRID: AB_893232), CD11c-PE-Cy7 (Biolegend Cat# 117318, RRID: AB_493568), Ly6c-APC-Fire750 (BioLegend Cat# 128046, RRID: AB_2616731), F4/80-BV421 (Biolegend Cat# 123137, RRID: AB_2563102), Ly6G-PE (BioLegend Cat# 127608, RRID: AB_1186099), CD103-BV785 (Biolegend Cat# 121439, RRID: AB_2800588) and I-A/I-E-BV605 (Biolegend Cat# 107639, RRID: AB_2565894).</td><td style="min-width:100px;border-bottom:1px solid lightgray"><div style="margin-bottom:8px"><div>anti-mouse</div><div>detected: (BioLegend Cat# 127608, RRID:AB_1186099)</div></div><div style="margin-bottom:8px"><div>CD19-FITC</div><div>suggested: None</div></div><div style="margin-bottom:8px"><div>anti-mouse antibodies</div><div>detected: (BioLegend Cat# 152404, RRID:AB_2629813)</div></div><div style="margin-bottom:8px"><div>CD11b-PerCP/Cy5.5</div><div>suggested: None</div></div><div style="margin-bottom:8px"><div></div><div>detected: (BioLegend Cat# 101228, RRID:AB_893232)</div></div><div style="margin-bottom:8px"><div>CD11c-PE-Cy7</div><div>suggested: None</div></div><div style="margin-bottom:8px"><div></div><div>detected: (BioLegend Cat# 117318, RRID:AB_493568)</div></div><div style="margin-bottom:8px"><div>Ly6c-APC-Fire750</div><div>suggested: None</div></div><div style="margin-bottom:8px"><div></div><div>detected: (BioLegend Cat# 128046, RRID:AB_2616731)</div></div><div style="margin-bottom:8px"><div>F4/80-BV421</div><div>suggested: None</div></div><div style="margin-bottom:8px"><div></div><div>detected: (BioLegend Cat# 123137, RRID:AB_2563102)</div></div><div style="margin-bottom:8px"><div>Ly6G-PE</div><div>suggested: None</div></div><div style="margin-bottom:8px"><div>CD103-BV785</div><div>suggested: None</div></div><div style="margin-bottom:8px"><div></div><div>detected: (BioLegend Cat# 121439, RRID:AB_2800588)</div></div><div style="margin-bottom:8px"><div>I-A/I-E-BV605</div><div>suggested: None</div></div><div style="margin-bottom:8px"><div>I-A/I-E-BV605</div><div>detected: (BioLegend Cat# 107639, RRID:AB_2565894)</div></div></td></tr><tr><td style="min-width:100px;vertical-align:top;border-bottom:1px solid lightgray">After overnight incubation, cells were washed with staining buffer (PBS containing 2% FBS) and surface stained with anti-mouse-CD4-PerCP/Cy5.5 (Biolegend Cat# 116012, RRID: AB_2563023), anti-mouse-CD8-BV785 (Biolegend Cat# 100750, RRID: AB_2562610)</td><td style="min-width:100px;border-bottom:1px solid lightgray"><div style="margin-bottom:8px"><div>with anti-mouse-CD4-PerCP/Cy5.5</div><div>detected: (BioLegend Cat# 116012, RRID:AB_2563023)</div></div><div style="margin-bottom:8px"><div>anti-mouse-CD8-BV785</div><div>detected: (BioLegend Cat# 100750, RRID:AB_2562610)</div></div></td></tr><tr><td style="min-width:100px;vertical-align:top;border-bottom:1px solid lightgray">, anti-mouse CD69-BV711 (Biolegend Cat# 104537, RRID: AB_2566120) and anti-mouse CD103-BV421 (Biolegend Cat# 121422, RRID: AB_2562901)</td><td style="min-width:100px;border-bottom:1px solid lightgray"><div style="margin-bottom:8px"><div>anti-mouse CD69-BV711</div><div>detected: (BioLegend Cat# 104537, RRID:AB_2566120)</div></div><div style="margin-bottom:8px"><div>anti-mouse</div><div>detected: (BioLegend Cat# 121422, RRID:AB_2562901)</div></div></td></tr><tr><td style="min-width:100px;vertical-align:top;border-bottom:1px solid lightgray">For intracellular staining, cells were fixed and permeabilized with BD Cytofix/Cytoperm (BD Biosciences) prior to staining with anti-mouse-IFN-γ-APC (Biolegend Cat# 505810, RRID: AB_315404), anti-mouse-TNF-α-PE (Biolegend Cat# 506306, RRID: AB_315427) and anti-mouse-IL-2-PE-Cy7 (Biolegend Cat# 503832, RRID: AB_2561750)</td><td style="min-width:100px;border-bottom:1px solid lightgray"><div style="margin-bottom:8px"><div>with anti-mouse-IFN-γ-APC</div><div>detected: (BioLegend Cat# 505810, RRID:AB_315404)</div></div><div style="margin-bottom:8px"><div>anti-mouse-TNF-α-PE</div><div>detected: (BioLegend Cat# 506306, RRID:AB_315427)</div></div><div style="margin-bottom:8px"><div>anti-mouse-IL-2-PE-Cy7</div><div>detected: (BioLegend Cat# 503832, RRID:AB_2561750)</div></div></td></tr><tr><td style="min-width:100px;vertical-align:top;border-bottom:1px solid lightgray">For identification and localization of SARS-CoV-2 nucleocapsid protein (NP) in organ tissues, IF staining was performed on deparaffinized and rehydrated tissue sections using rabbit anti-SARS-CoV-2-N protein antibody together with AF568-conjugated goat anti-rabbit IgG (Invitrogen).</td><td style="min-width:100px;border-bottom:1px solid lightgray"><div style="margin-bottom:8px"><div>SARS-CoV-2 nucleocapsid protein (NP</div><div>suggested: None</div></div><div style="margin-bottom:8px"><div>anti-SARS-CoV-2-N protein</div><div>suggested: None</div></div><div style="margin-bottom:8px"><div>anti-rabbit IgG</div><div>suggested: None</div></div></td></tr><tr><td style="min-width:100px;vertical-align:top;border-bottom:1px solid lightgray">After blocking with 0.1% Sudan black B for 15 min and 1% bovine serum albumin (BSA)/PBS at RT for 30 min, the primary antibody rabbit anti-SARS-CoV-2-N antibody (1:4000 dilution with 1% BSA/PBS) was incubated at 4°C overnight.</td><td style="min-width:100px;border-bottom:1px solid lightgray"><div style="margin-bottom:8px"><div>anti-SARS-CoV-2-N</div><div>suggested: None</div></div></td></tr><tr><th style="min-width:100px;text-align:center; padding-top:4px;" colspan="2">Experimental Models: Cell Lines</th></tr><tr><td style="min-width:100px;text=align:center">Sentences</td><td style="min-width:100px;text-align:center">Resources</td></tr><tr><td style="min-width:100px;vertical-align:top;border-bottom:1px solid lightgray">2.2 Cell lines: HEK 293T-hACE2 and Vero E6 cells (RRID:CVCL_0574) were maintained in Dulbecco’s Modified Eagle Medium (DMEM) (Thermo Fisher Scientific) containing 10% fetal bovine serum, 2 mM L-glutamine and 100 U/mL penicillin and were incubated at 37□ in 5% CO2 setting (22). 2.3</td><td style="min-width:100px;border-bottom:1px solid lightgray"><div style="margin-bottom:8px"><div>HEK 293T-hACE2</div><div>suggested: None</div></div><div style="margin-bottom:8px"><div>Vero E6</div><div>detected: (IZSLER Cat# BS CL 87, RRID:CVCL_0574)</div></div></td></tr><tr><td style="min-width:100px;vertical-align:top;border-bottom:1px solid lightgray">Viruses: Confluent Vero-E6 cells were infected at 0.01 MOI with live SARS-CoV-2 HKU-13 strain (GenBank accession number MT835140).</td><td style="min-width:100px;border-bottom:1px solid lightgray"><div style="margin-bottom:8px"><div>Vero-E6</div><div>suggested: None</div></div></td></tr><tr><td style="min-width:100px;vertical-align:top;border-bottom:1px solid lightgray">The plasmid DNA transfection into HEK 293T cells was performed using polyethylenimine (PEI), and protein expression was detected by Western blot.</td><td style="min-width:100px;border-bottom:1px solid lightgray"><div style="margin-bottom:8px"><div>HEK 293T</div><div>suggested: CCLV Cat# CCLV-RIE 1018, RRID:CVCL_0063)</div></div></td></tr><tr><td style="min-width:100px;vertical-align:top;border-bottom:1px solid lightgray">To rescue the virus, eight pHW2000 plasmids containing the DelNS1-RBD and the other 7 influenza virus genomic segments, together with an NS1 expression plasmid, were transfected into 293T cells using Transit-LT1 (Mirus) according to the manufacturer protocol.</td><td style="min-width:100px;border-bottom:1px solid lightgray"><div style="margin-bottom:8px"><div>293T</div><div>suggested: CCLV Cat# CCLV-RIE 1018, RRID:CVCL_0063)</div></div></td></tr><tr><td style="min-width:100px;vertical-align:top;border-bottom:1px solid lightgray">Viruses were aliquoted and titrated by plaque assay using MDCK cells.</td><td style="min-width:100px;border-bottom:1px solid lightgray"><div style="margin-bottom:8px"><div>MDCK</div><div>suggested: CLS Cat# 602280/p823_MDCK_(NBL-2, RRID:CVCL_0422)</div></div></td></tr><tr><th style="min-width:100px;text-align:center; padding-top:4px;" colspan="2">Experimental Models: Organisms/Strains</th></tr><tr><td style="min-width:100px;text=align:center">Sentences</td><td style="min-width:100px;text-align:center">Resources</td></tr><tr><td style="min-width:100px;vertical-align:top;border-bottom:1px solid lightgray">2.1 Mice: Male and female BALB/c and K18-hACE2 mice (aged 6–10 weeks) were obtained from the HKU Laboratory Animal Unit</td><td style="min-width:100px;border-bottom:1px solid lightgray"><div style="margin-bottom:8px"><div>K18-hACE2</div><div>suggested: RRID:IMSR_GPT:T037657)</div></div></td></tr><tr><td style="min-width:100px;vertical-align:top;border-bottom:1px solid lightgray">The transduced BALB/c mice or K18-ACE2 transgenic mice were intranasally infected with live wild type SARS-CoV-2 (HKU clone 13) at a dose of 1×104 PFU.</td><td style="min-width:100px;border-bottom:1px solid lightgray"><div style="margin-bottom:8px"><div>BALB/c</div><div>suggested: None</div></div></td></tr><tr><th style="min-width:100px;text-align:center; padding-top:4px;" colspan="2">Recombinant DNA</th></tr><tr><td style="min-width:100px;text=align:center">Sentences</td><td style="min-width:100px;text-align:center">Resources</td></tr><tr><td style="min-width:100px;vertical-align:top;border-bottom:1px solid lightgray">vaccine: Codon-optimized SARS-CoV-2 RBD gene was in fusion to a human soluble PD1 domain (PD1-RBD) using the pVAX plasmid as the backbone.</td><td style="min-width:100px;border-bottom:1px solid lightgray"><div style="margin-bottom:8px"><div>pVAX</div><div>suggested: RRID:Addgene_141350)</div></div></td></tr><tr><td style="min-width:100px;vertical-align:top;border-bottom:1px solid lightgray">The pHW2000-DelNS1-RBD plasmid was constructed by inserting the tPA-linked RBD between the noncoding region (NCR) and autoproteolytic cleavage site (2A) in the pHW2000-DelNS1 plasmid.</td><td style="min-width:100px;border-bottom:1px solid lightgray"><div style="margin-bottom:8px"><div>pHW2000-DelNS1-RBD</div><div>suggested: None</div></div><div style="margin-bottom:8px"><div>pHW2000-DelNS1</div><div>suggested: None</div></div></td></tr><tr><td style="min-width:100px;vertical-align:top;border-bottom:1px solid lightgray">To rescue the virus, eight pHW2000 plasmids containing the DelNS1-RBD and the other 7 influenza virus genomic segments, together with an NS1 expression plasmid, were transfected into 293T cells using Transit-LT1 (Mirus) according to the manufacturer protocol.</td><td style="min-width:100px;border-bottom:1px solid lightgray"><div style="margin-bottom:8px"><div>pHW2000</div><div>suggested: None</div></div></td></tr><tr><td style="min-width:100px;vertical-align:top;border-bottom:1px solid lightgray">In brief, different SARS-CoV-2 pseudotype viruses were generated through co-transfection of 293T cells with 2 plasmids, pSARS-CoV-2 S and pNL4-3Luc_Env_Vpr, carrying the optimized SARS-CoV-2 S gene and a human immunodeficiency virus type 1 backbone, respectively.</td><td style="min-width:100px;border-bottom:1px solid lightgray"><div style="margin-bottom:8px"><div>pNL4-3Luc_Env_Vpr</div><div>suggested: None</div></div></td></tr><tr><th style="min-width:100px;text-align:center; padding-top:4px;" colspan="2">Software and Algorithms</th></tr><tr><td style="min-width:100px;text=align:center">Sentences</td><td style="min-width:100px;text-align:center">Resources</td></tr><tr><td style="min-width:100px;vertical-align:top;border-bottom:1px solid lightgray">Area under the curve (AUC) was measured using GraphPad Prism v8, setting the baseline with the defined endpoint (average of negative control wells + 10 standard deviation) and taking the total peak area as previous described (27).</td><td style="min-width:100px;border-bottom:1px solid lightgray"><div style="margin-bottom:8px"><div>GraphPad Prism</div><div>suggested: (GraphPad Prism, RRID:SCR_002798)</div></div></td></tr><tr><td style="min-width:100px;vertical-align:top;border-bottom:1px solid lightgray">For intracellular staining, cells were fixed and permeabilized with BD Cytofix/Cytoperm (BD Biosciences) prior to staining with anti-mouse-IFN-γ-APC (Biolegend Cat# 505810, RRID: AB_315404), anti-mouse-TNF-α-PE (Biolegend Cat# 506306, RRID: AB_315427) and anti-mouse-IL-2-PE-Cy7 (Biolegend Cat# 503832, RRID: AB_2561750)</td><td style="min-width:100px;border-bottom:1px solid lightgray"><div style="margin-bottom:8px"><div>BD Cytofix/Cytoperm</div><div>suggested: None</div></div></td></tr><tr><td style="min-width:100px;vertical-align:top;border-bottom:1px solid lightgray">Stained cells were acquired by FACSAriaIII Flow Cytometer (BD Biosciences) and analyzed with FlowJo software (v10.6) (BD Bioscience).</td><td style="min-width:100px;border-bottom:1px solid lightgray"><div style="margin-bottom:8px"><div>FlowJo</div><div>suggested: (FlowJo, RRID:SCR_008520)</div></div></td></tr><tr><td style="min-width:100px;vertical-align:top;border-bottom:1px solid lightgray">All tissue sections were examined, the images were captured with a Carl Zeiss LSM780 confocal microscope, and the mean fluorescence intensity (MFI) was further measured by ImageJ v1.53c.</td><td style="min-width:100px;border-bottom:1px solid lightgray"><div style="margin-bottom:8px"><div>ImageJ</div><div>suggested: (ImageJ, RRID:SCR_003070)</div></div></td></tr><tr><td style="min-width:100px;vertical-align:top;border-bottom:1px solid lightgray">2.12 Statistical analysis: Statistical analysis was performed with the GraphPad Prism 8 Software.</td><td style="min-width:100px;border-bottom:1px solid lightgray"><div style="margin-bottom:8px"><div>GraphPad</div><div>suggested: (GraphPad Prism, RRID:SCR_002798)</div></div></td></tr></table>
Results from OddPub: We did not detect open data. We also did not detect open code. Researchers are encouraged to share open data when possible (see Nature blog).
Results from LimitationRecognizer: We detected the following sentences addressing limitations in the study:Although intramuscular electroporation delivery has potential limitation for DNA vaccination in large populations, this approach has demonstrated the safety, tolerability and immunogenicity profile for SARS-CoV-2 DNA vaccines in clinical trials (61). Future study, however, is needed to develop non-invasive delivery techniques for DNA vaccination in humans. In addition, simultaneous or sequential co-infection by SARS-CoV-2 and A(H1N1)pdm09 caused more severe disease than infection by either virus (62), our LAIV platform may offer an opportunity of generating a human vaccine to fight both COVID-19 and influenza.
Results from TrialIdentifier: We found the following clinical trial numbers in your paper:<br><table><td style="min-width:95px; border-right:1px solid lightgray; border-bottom:1px solid lightgray">Identifier</td><td style="min-width:95px; border-right:1px solid lightgray; border-bottom:1px solid lightgray">Status</td><td style="min-width:95px; border-right:1px solid lightgray; border-bottom:1px solid lightgray">Title</td></tr><tr><td style="min-width:95px; border-right:1px solid lightgray; border-bottom:1px solid lightgray">NCT04809389</td><td style="min-width:95px; border-right:1px solid lightgray; border-bottom:1px solid lightgray">Active, not recruiting</td><td style="min-width:95px; border-right:1px solid lightgray; border-bottom:1px solid lightgray">A Study to Evaluate Safety and Immunogenicity of DelNS1-nCoV…</td></tr></table>
Results from Barzooka: We did not find any issues relating to the usage of bar graphs.
Results from JetFighter: Please consider improving the rainbow (“jet”) colormap(s) used on page 30. At least one figure is not accessible to readers with colorblindness and/or is not true to the data, i.e. not perceptually uniform.
Results from rtransparent: - Thank you for including a conflict of interest statement. Authors are encouraged to include this statement when submitting to a journal.
- Thank you for including a funding statement. Authors are encouraged to include this statement when submitting to a journal.
- No protocol registration statement was detected.
Results from scite Reference Check: We found no unreliable references.
<footer>About SciScore
SciScore is an automated tool that is designed to assist expert reviewers by finding and presenting formulaic information scattered throughout a paper in a standard, easy to digest format. SciScore checks for the presence and correctness of RRIDs (research resource identifiers), and for rigor criteria such as sex and investigator blinding. For details on the theoretical underpinning of rigor criteria and the tools shown here, including references cited, please follow this link.
</footer>